Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

The identification of the optimal cancer treatment has become progressively more intricate for non-small-cell lung cancer (NSCLC) patients due to the multitude of options available. The testing of biomarkers to predict clinical responses to therapies is pivotal to stratify the patients based on the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Normanno, Nicola, Barberis, Massimo, De Marinis, Filippo, Gridelli, Cesare
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Perspective
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352587/
https://ncbi.nlm.nih.gov/pubmed/32575424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061627
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge